Studying the private pharmacy market in units during the Pre and COVID periods, based on sales data from Pharmacy Insights Hellas from a weighted panel of pharmacies across the country, it is revealed that:
➖ Overall, the pharmacy market for prescription and OTC products experienced a decline of -2.2%.
➖ Prescription medications showed good performance with a +3.2% increase.
➖ OTC products had a significant decrease of -8.1%.
According to the detailed data:
➖ The pulmonology category experienced the largest decline, with -15.1% in reimbursed products and -36.3% in OTC products.
➖ Gaining categories are:
◾ Digestive system and metabolism (+5.8%) in reimbursed products
◾ Dermatological products (+7.6%) in OTC products.
In conclusion, pharmacy visitors were limited to fulfilling prescriptions, partially abandoning self-care purchases, a trend that is also confirmed by the decline in the para-pharmaceutical market.
